QSAR analysis of caffeoyl naphthalene sulfonamide derivatives as HIV-1 integrase inhibitors

Medicinal Chemistry Research

Volumn 15, Issue 7-8, 2007, Pages 418-430

  Sahu, Kamlesh Kumar ^a   Ravichandran, Veerasamy ^a   Mourya, Vishnu Kant ^b   Agrawal, Ram Kishore ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b GOVERNMENT COLLEGE OF PHARMACY   (India)

Author keywords

Caffeoyl; Human immunodeficiency virus; Inhibition; Integrase; Partition coefficient; Quantitative structure activity relationship; Sulfonamide; Total energy

Indexed keywords

CAFFEOYL NAPHTHALENE SULFONAMIDE; INTEGRASE INHIBITOR; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; DRUG ACTIVITY; DRUG POTENCY; DRUG TARGETING; HUMAN IMMUNODEFICIENCY VIRUS 1; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTITION COEFFICIENT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

EID: 34948822189     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-006-0020-2     Document Type: Article

References (18)

1. Carteau S, Mouscadet JF, Goulaouic H, Subra F, Auclair C (1993) Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction. Biochem Biophys Res Commun 192:1409
2. Chen IJ, Neamati N, Nicklaus MC, Orr A, Anderson L, Barchi JJ Jr, Kelly JA, Pommier Y, MacKerell AD Jr (2000) Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targets. Bioorg Med Chem 8:2385
3. Craigie R, Fujiwara T, Bushman F (1990) The IN protein of Moloney murine leukemia virus processes the DNA viral ends and accomplishes their integration in vitro. Cell 62:829
4. Cushman M, Sherman P (1992) Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem Biophys Res Commun 185:58
5. De Clercq E (1995) Toward improved anti-HIV chemotheraphy: therapeutic strategies for intervention with HIV infections. J Med Chem 38:2491
6. Eich E, Pertz H, Kaloga M, Schulz J, Fesen MR, Mazumder A, Pommier Y (1996) (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J Med Chem 39:86
7. Fesen MR, Kohn KW, Leteurtre F, Pommier Y (1993) Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci USA 90:2399
8. Hansch C (1969) A quantitative approach to biochemical structure-activity relationships. Acc Chem Res 2:232
9. Katz RA, Merkel G, Kulkosk T, Leis J, Salka AM (1990) The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63:87
10. Mazumder A, Raghawan K, Weinstein J, Kohn KW, Pommier Y (1995) Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 49:1165
11. Mazumder A, Neamati N, Sommadossi JP, Gosseli G, Schinazi RF, Pommier Y (1996) Effects of nucleotide analogues on human immunodeficiency virus type 1 intrgrase. Mol Pharmacol 49:621
12. Mouscadet JF, Carteau S, Goulaouic H, Subra F, Auclair C (1994) Triplex-mediated inhibition of HIV DNA integration in vitro. J Biol Chem 269:21635
13. Neamati N (2002) Patented small molecule inhibitors of HIV-1 integrase: a 10-year saga. Expert Opin Ther Patents 12:709
14. Parril AL (2003) HIV-1 integrase inhibition: binding sites, structure activity relationships and future perspectives. Curr Med Chem 10:1811
15. Robinson WE Jr, Cordeiro M, Abdel-Malek S, Jia Q, Chow SA, Reineck MG, Mitchell WM (1996a) Dicaffeoylguinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol Pharmacol 50:846
16. Robinson WE Jr, Reineck MG, Abdel-Malek S, Jia Q, Chow SA (1996b) Inhibitors of HIV-1 replication inhibit HIV integrase. Proc Natl Acad Sci USA 93:6326
17. Santo RD, Costi R, Artico M, Tramontano E, Colla PL, Pani A (2003) HIV-1 integrase inhibitors that block HIV-1 replication in infected cells. Planning synthetic derivatives from natural products. Pure Appl Chem 75:195
18. Xu YW, Zhao GS, Shin CG, Zang HC, Lee CK, Lee YS (2003) Caffeoyl naphtalenesulfonamide derivatives as HIV integrase inhibitors. Bioorg Med Chem 11:3589